The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: A next step in histology-driven immunotherapy

Salivary gland carcinomas (SGC) are extremely rare malignancies with only limited treatment options for the metastatic phase of the disease. Treatment with anti-CD47 antibodies could represent a potent therapy for SGCs by promoting the phagocytic clearance of tumor cells through various mechanisms.